Overcoming mTOR resistance mutations with a new-generation mTOR inhibitor Journal Article


Authors: Rodrik-Outmezguine, V. S.; Okaniwa, M.; Yao, Z.; Novotny, C. J.; McWhirter, C.; Banaji, A.; Won, H.; Wong, W.; Berger, M.; De Stanchina, E.; Barratt, D. G.; Cosulich, S.; Klinowska, T.; Rosen, N.; Shokat, K. M.
Article Title: Overcoming mTOR resistance mutations with a new-generation mTOR inhibitor
Abstract: Precision medicines exert selective pressure on tumour cells that leads to the preferential growth of resistant subpopulations, necessitating the development of next-generation therapies to treat the evolving cancer. The PIK3CA-AKT-mTOR pathway is one of the most commonly activated pathways in human cancers, which has led to the development of small-molecule inhibitors that target various nodes in the pathway. Among these agents, first-generation mTOR inhibitors (rapalogs) have caused responses in 'N-of-1' cases, and second-generation mTOR kinase inhibitors (TORKi) are currently in clinical trials. Here we sought to delineate the likely resistance mechanisms to existing mTOR inhibitors in human cell lines, as a guide for next-generation therapies. The mechanism of resistance to the TORKi was unusual in that intrinsic kinase activity of mTOR was increased, rather than a direct active-site mutation interfering with drug binding. Indeed, identical drug-resistant mutations have been also identified in drug-naive patients, suggesting that tumours with activating MTOR mutations will be intrinsically resistant to second-generation mTOR inhibitors. We report the development of a new class of mTOR inhibitors that overcomes resistance to existing first- and second-generation inhibitors. The third-generation mTOR inhibitor exploits the unique juxtaposition of two drug-binding pockets to create a bivalent interaction that allows inhibition of these resistant mutants. © 2016 Macmillan Publishers Limited. All rights reserved.
Journal Title: Nature
Volume: 534
Issue: 7606
ISSN: 0028-0836
Publisher: Nature Publishing Group  
Date Published: 2016-06-09
Start Page: 272
End Page: 276
Language: English
DOI: 10.1038/nature17963
PROVIDER: scopus
PMCID: PMC4902179
PUBMED: 27279227
DOI/URL:
Notes: Article -- Export Date: 1 July 2016 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Neal Rosen
    425 Rosen
  2. Michael Forman Berger
    765 Berger
  3. Helen Hyeong-Eun Won
    109 Won
  4. Zhan Yao
    38 Yao
  5. Wai Pung Elissa Wong
    21 Wong
  6. Arpitha   Banaji
    1 Banaji